Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis

Author： Saraogi Gaurav Kant   Sharma Bhavna   Joshi Beenu   Gupta Pushpa   Gupta Umesh Dutta   Jain Narendra Kumar   Agrawal Govind Prasad  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.19, Iss.3, 2011-04, pp. : 219-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice

By Lee Gee Young   Park Kyeongsoon   Nam Jong Hee   Kim Sang Yoon   Byun Youngro  

Journal of Drug Targeting, Vol. 14, Iss. 10, 2006-12 ,pp. : 707-716

Informa Healthcare

Access to resources Recommend Favorite

Development and Optimization of Dual Drugs (Isoniazid and Moxiflox-acin) Loaded Functional PLGA Nanoparticles for the Synergistic Treatment of Tuberculosis

By  

Current Drug Delivery, Vol. 13, Iss. 7, 2016-10 ,pp. : 1034-1052

Bentham Science Publishers

Access to resources Recommend Favorite

Isoniazid and its Hydrazine Metabolite in Patients with Tuberculosis

By Pea F.  

Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. : 145-154

Adis International

Access to resources Recommend Favorite

Microencapsulation of isoniazid in genipin-crosslinked gelatin-A–κ-carrageenan polyelectrolyte complex

By Devi Nirmala   Maji Tarun K.  

Drug Development and Industrial Pharmacy, Vol. 36, Iss. 1, 2010-01 ,pp. : 56-63

Informa Healthcare

Access to resources Recommend Favorite

Isoniazid programme to prevent TB cost effective in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite